US Stock MarketDetailed Quotes

INKT MiNK Therapeutics

Watchlist
  • 0.928
  • +0.056+6.46%
Close Apr 26 16:00 ET
  • 0.975
  • +0.047+5.10%
Post 19:22 ET
32.18MMarket Cap-1426P/E (TTM)

MiNK Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
16.45%-15.76M
31.48%-3.04M
25.03%-4.21M
10.25%-4.15M
-4.05%-4.37M
-47.09%-18.87M
-160.27%-4.43M
-60.61%-5.61M
-35.23%-4.63M
0.29%-4.2M
Net income from continuing operations
19.77%-22.46M
29.75%-5.46M
19.20%-5.12M
-1.38%-6.2M
26.89%-5.69M
7.35%-27.99M
-34.79%-7.77M
55.62%-6.33M
3.51%-6.11M
-102.20%-7.78M
Operating gains losses
90.44%-266.78K
----
----
----
----
-685.00%-2.79M
----
----
----
----
Depreciation and amortization
68.06%204.62K
41.23%53.57K
88.02%53.45K
83.36%51.91K
68.73%45.69K
56.17%121.75K
59.15%37.93K
40.15%28.43K
60.42%28.31K
67.20%27.08K
Change In working capital
-66.95%2.9M
-51.88%1.27M
-1.38%-85.6K
-60.50%1.36M
-87.25%352.81K
134.64%8.77M
-20.71%2.63M
-113.84%-84.44K
556.92%3.45M
483.94%2.77M
-Change in prepaid assets
182.71%245.59K
69.00%-11.08K
241.01%223.52K
-45.56%43.16K
94.50%-10.01K
-160.76%-296.95K
-425.02%-35.74K
-200.91%-158.51K
-82.62%79.28K
-34.33%-181.97K
-Change in payables and accrued expense
-98.23%107.57K
-63.36%891.2K
-300.26%-969.15K
-56.48%581.12K
-121.57%-395.61K
2,808.98%6.09M
4,280.30%2.43M
1,619.19%483.94K
1,002.37%1.34M
1,243.70%1.83M
-Change in other working capital
-14.57%2.54M
63.49%387.27K
261.04%660.03K
-63.72%738.26K
-32.05%758.42K
-14.23%2.98M
-92.72%236.88K
-196.43%-409.86K
837.99%2.03M
362.53%1.12M
Cash from discontinued investing activities
Operating cash flow
16.45%-15.76M
31.48%-3.04M
25.03%-4.21M
10.25%-4.15M
-4.05%-4.37M
-47.09%-18.87M
-160.27%-4.43M
-60.61%-5.61M
-35.23%-4.63M
0.29%-4.2M
Investing cash flow
Cash flow from continuing investing activities
70.58%-73.56K
0
61.46%-23.04K
40.69%-37.02K
-13.5K
-0.43%-250.05K
-46,250.90%-127.84K
46.53%-59.8K
36.26%-62.41K
0
Net PPE purchase and sale
70.58%-73.56K
--0
61.46%-23.04K
40.69%-37.02K
---13.5K
-0.43%-250.05K
-46,250.90%-127.84K
46.53%-59.8K
36.26%-62.41K
--0
Cash from discontinued investing activities
Investing cash flow
70.58%-73.56K
--0
61.46%-23.04K
40.69%-37.02K
---13.5K
-0.43%-250.05K
-46,250.90%-127.84K
46.53%-59.8K
36.26%-62.41K
--0
Financing cash flow
Cash flow from continuing financing activities
-161.68%-407.17K
-101.80%-2
497.57%2.95K
51.75%-75.7K
-48,637.74%-334.43K
-100.32%-155.6K
-100.00%111
-99.98%494
-103.60%-156.89K
-99.97%689
Net common stock issuance
-203.85%-477.64K
---2
--2
37.84%-97.72K
---379.92K
-100.39%-157.19K
--0
--0
---157.19K
--0
Proceeds from stock option exercised by employees
4,317.93%70.47K
--0
497.17%2.95K
7,215.61%22.02K
6,503.19%45.5K
963.33%1.6K
--111
229.33%494
--301
--689
Cash from discontinued financing activities
Financing cash flow
-161.68%-407.17K
-101.80%-2
497.57%2.95K
51.75%-75.7K
-48,637.74%-334.43K
-100.32%-155.6K
-100.00%111
-99.98%494
-103.60%-156.89K
-99.97%689
Net cash flow
Beginning cash position
-49.51%19.64M
-73.51%6.4M
-64.41%10.62M
-57.07%14.89M
-49.51%19.64M
1,345.06%38.89M
2,848.15%24.16M
1,699.80%29.85M
4,181.08%34.69M
1,345.06%38.89M
Current changes in cash
15.72%-16.24M
33.40%-3.04M
25.46%-4.23M
11.99%-4.26M
-12.36%-4.71M
-153.27%-19.27M
-111.97%-4.56M
-587.79%-5.67M
-680.77%-4.84M
-118.11%-4.2M
Effect of exchange rate changes
-230.26%-25.25K
-87.82%4.31K
141.32%5.91K
-313.01%-6.12K
-539.77%-29.34K
14.71%19.39K
236.54%35.39K
-2.59%-14.29K
-79.37%2.88K
-110.71%-4.59K
End cash Position
-82.85%3.37M
-82.85%3.37M
-73.51%6.4M
-64.41%10.62M
-57.07%14.89M
-49.51%19.64M
-49.51%19.64M
2,848.15%24.16M
1,699.80%29.85M
4,181.08%34.69M
Free cash flow
17.16%-15.84M
33.40%-3.04M
25.42%-4.23M
10.66%-4.19M
-4.37%-4.38M
-46.20%-19.12M
-167.82%-4.56M
-57.29%-5.67M
-33.24%-4.69M
1.22%-4.2M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 16.45%-15.76M31.48%-3.04M25.03%-4.21M10.25%-4.15M-4.05%-4.37M-47.09%-18.87M-160.27%-4.43M-60.61%-5.61M-35.23%-4.63M0.29%-4.2M
Net income from continuing operations 19.77%-22.46M29.75%-5.46M19.20%-5.12M-1.38%-6.2M26.89%-5.69M7.35%-27.99M-34.79%-7.77M55.62%-6.33M3.51%-6.11M-102.20%-7.78M
Operating gains losses 90.44%-266.78K-----------------685.00%-2.79M----------------
Depreciation and amortization 68.06%204.62K41.23%53.57K88.02%53.45K83.36%51.91K68.73%45.69K56.17%121.75K59.15%37.93K40.15%28.43K60.42%28.31K67.20%27.08K
Change In working capital -66.95%2.9M-51.88%1.27M-1.38%-85.6K-60.50%1.36M-87.25%352.81K134.64%8.77M-20.71%2.63M-113.84%-84.44K556.92%3.45M483.94%2.77M
-Change in prepaid assets 182.71%245.59K69.00%-11.08K241.01%223.52K-45.56%43.16K94.50%-10.01K-160.76%-296.95K-425.02%-35.74K-200.91%-158.51K-82.62%79.28K-34.33%-181.97K
-Change in payables and accrued expense -98.23%107.57K-63.36%891.2K-300.26%-969.15K-56.48%581.12K-121.57%-395.61K2,808.98%6.09M4,280.30%2.43M1,619.19%483.94K1,002.37%1.34M1,243.70%1.83M
-Change in other working capital -14.57%2.54M63.49%387.27K261.04%660.03K-63.72%738.26K-32.05%758.42K-14.23%2.98M-92.72%236.88K-196.43%-409.86K837.99%2.03M362.53%1.12M
Cash from discontinued investing activities
Operating cash flow 16.45%-15.76M31.48%-3.04M25.03%-4.21M10.25%-4.15M-4.05%-4.37M-47.09%-18.87M-160.27%-4.43M-60.61%-5.61M-35.23%-4.63M0.29%-4.2M
Investing cash flow
Cash flow from continuing investing activities 70.58%-73.56K061.46%-23.04K40.69%-37.02K-13.5K-0.43%-250.05K-46,250.90%-127.84K46.53%-59.8K36.26%-62.41K0
Net PPE purchase and sale 70.58%-73.56K--061.46%-23.04K40.69%-37.02K---13.5K-0.43%-250.05K-46,250.90%-127.84K46.53%-59.8K36.26%-62.41K--0
Cash from discontinued investing activities
Investing cash flow 70.58%-73.56K--061.46%-23.04K40.69%-37.02K---13.5K-0.43%-250.05K-46,250.90%-127.84K46.53%-59.8K36.26%-62.41K--0
Financing cash flow
Cash flow from continuing financing activities -161.68%-407.17K-101.80%-2497.57%2.95K51.75%-75.7K-48,637.74%-334.43K-100.32%-155.6K-100.00%111-99.98%494-103.60%-156.89K-99.97%689
Net common stock issuance -203.85%-477.64K---2--237.84%-97.72K---379.92K-100.39%-157.19K--0--0---157.19K--0
Proceeds from stock option exercised by employees 4,317.93%70.47K--0497.17%2.95K7,215.61%22.02K6,503.19%45.5K963.33%1.6K--111229.33%494--301--689
Cash from discontinued financing activities
Financing cash flow -161.68%-407.17K-101.80%-2497.57%2.95K51.75%-75.7K-48,637.74%-334.43K-100.32%-155.6K-100.00%111-99.98%494-103.60%-156.89K-99.97%689
Net cash flow
Beginning cash position -49.51%19.64M-73.51%6.4M-64.41%10.62M-57.07%14.89M-49.51%19.64M1,345.06%38.89M2,848.15%24.16M1,699.80%29.85M4,181.08%34.69M1,345.06%38.89M
Current changes in cash 15.72%-16.24M33.40%-3.04M25.46%-4.23M11.99%-4.26M-12.36%-4.71M-153.27%-19.27M-111.97%-4.56M-587.79%-5.67M-680.77%-4.84M-118.11%-4.2M
Effect of exchange rate changes -230.26%-25.25K-87.82%4.31K141.32%5.91K-313.01%-6.12K-539.77%-29.34K14.71%19.39K236.54%35.39K-2.59%-14.29K-79.37%2.88K-110.71%-4.59K
End cash Position -82.85%3.37M-82.85%3.37M-73.51%6.4M-64.41%10.62M-57.07%14.89M-49.51%19.64M-49.51%19.64M2,848.15%24.16M1,699.80%29.85M4,181.08%34.69M
Free cash flow 17.16%-15.84M33.40%-3.04M25.42%-4.23M10.66%-4.19M-4.37%-4.38M-46.20%-19.12M-167.82%-4.56M-57.29%-5.67M-33.24%-4.69M1.22%-4.2M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg